Literature DB >> 17244848

Chronic distress, age-related neuropathology, and late-life dementia.

Robert S Wilson1, Steven E Arnold, Julie A Schneider, Yan Li, David A Bennett.   

Abstract

OBJECTIVE: The objective of this study was to test whether common age-related neuropathology could account for the relation of chronic distress to dementia.
METHODS: In a selected cohort of more than 1000 older Catholic clergy members undergoing annual clinical evaluations, 326 persons died, of whom 306 (94%) underwent brain autopsy, the results of which were available in 219 (mean age at death = 85.4, standard deviation [SD] = 6.6; mean postmortem interval = 7.6 hours, SD = 6.9). A composite measure of chronic distress was constructed from standard measures of two traits, neuroticism and anxiety proneness, completed at baseline, and of depressive symptoms, completed annually. Dementia was diagnosed according to standard criteria and cognition was assessed with previously established composite measures based on a uniform clinical evaluation that took place a mean of 9.1 months before death (SD = 9.5). On postmortem examination, levels of amyloid-beta and tau-positive neurofibrillary tangles and the presence of Lewy bodies were quantified in six brain regions, and the number and location of chronic cerebral infarctions were noted.
RESULTS: In analyses that controlled for age, sex, education, amyloid, tangles, Lewy bodies, and cerebral infarction, higher level of chronic distress was associated with a higher likelihood of dementia and lower level of cognition proximate to death. Chronic distress was not correlated with any form of neuropathology, including limbic, neocortical, and global indices, and did not modify the association of pathology with cognition.
CONCLUSIONS: Chronic psychological distress is associated with late-life dementia but not with its leading causes, suggesting that novel neurodeteriorative mechanisms may be involved.

Entities:  

Mesh:

Year:  2007        PMID: 17244848     DOI: 10.1097/01.psy.0000250264.25017.21

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  54 in total

1.  The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease.

Authors:  Lei Yu; Joshua M Shulman; Lori Chibnik; Sue Leurgans; Julie A Schneider; Philip L De Jager; David A Bennett
Journal:  Aging Cell       Date:  2011-12-29       Impact factor: 9.304

2.  Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.

Authors:  Ainie Soetanto; Robert S Wilson; Konrad Talbot; Ashley Un; Julie A Schneider; Mark Sobiesk; Jeremiah Kelly; Sue Leurgans; David A Bennett; Steven E Arnold
Journal:  Arch Gen Psychiatry       Date:  2010-05

3.  Intrusive Thoughts Mediate the Association between Neuroticism and Cognitive Function.

Authors:  Elizabeth Munoz; Martin J Sliwinski; Joshua M Smyth; David M Almeida; Heather A King
Journal:  Pers Individ Dif       Date:  2013-11-01

4.  Vulnerability to stress, anxiety, and development of dementia in old age.

Authors:  Robert S Wilson; Christopher T Begeny; Patricia A Boyle; Julie A Schneider; David A Bennett
Journal:  Am J Geriatr Psychiatry       Date:  2011-04       Impact factor: 4.105

Review 5.  Neuroimaging biomarkers in mild traumatic brain injury (mTBI).

Authors:  Erin D Bigler
Journal:  Neuropsychol Rev       Date:  2013-08-24       Impact factor: 7.444

Review 6.  Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

Authors:  S Negash; D A Bennett; R S Wilson; J A Schneider; S E Arnold
Journal:  Curr Alzheimer Res       Date:  2011-06       Impact factor: 3.498

7.  Implications of Differential Associations of Neuroticism Facets with Cognitive Function in Late-Life Depression.

Authors:  Benjamin P Chapman
Journal:  Am J Geriatr Psychiatry       Date:  2016-12-21       Impact factor: 4.105

8.  3xTg-AD mice exhibit an activated central stress axis during early-stage pathology.

Authors:  Elaine K Hebda-Bauer; Tracy A Simmons; Andrew Sugg; Eren Ural; James A Stewart; James L Beals; Qiang Wei; Stanley J Watson; Huda Akil
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  Epigenetic drugs for Alzheimer's disease: hopes and challenges.

Authors:  Filippo Caraci; Gian Marco Leggio; Filippo Drago; Salvatore Salomone
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

Review 10.  Adverse stress, hippocampal networks, and Alzheimer's disease.

Authors:  Sarah M Rothman; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2009-11-27       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.